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Abstract
Background: The use and benefits of normobaric oxygen (NBO) in patients suffering acute ischemic stroke is still
controversial.
Results: Here we show for the first time to the best of our knowledge that NBO reduces both NMDA-induced
calcium influxes in vitro and NMDA-induced neuronal degeneration in vivo, but increases oxygen and glucose
deprivation-induced cell injury in vitro and ischemia-induced brain damage produced by middle cerebral artery
occlusion in vivo.
Conclusions: Taken together, these results indicate that NBO reduces excitotoxin-induced calcium influx and
subsequent neuronal degeneration but favors ischemia-induced brain damage and neuronal death. These findings
highlight the complexity of the mechanisms involved by the use of NBO in patients suffering acute ischemic stroke.
Background
Acute ischemic stroke is one of the most common
causes of death and long-term neurologic morbidity in
the adult population. The primary cause of acute
ischemic stroke is a significant disruption of cerebral
blood flow through thromboembolism that leads to an
oxygen and glucose deprivation for the cell and subse-
quent over-stimulation of the excitatory N-methyl-D-
aspartate (NMDA) glutamatergic receptor whose post-
synaptic activation is known as a critical event in neuro-
nal death and brain damage induced by acute ischemic
stroke [1,2]. The most common approved therapy of
acute ischemic stroke today is thrombolysis, but unfor-
tunately thrombolytic therapies are substantially limited
to about 2% of stroke patients mainly due to some con-
traindications to treatment and most importantly to nar-
row therapeutic time window [3]. Alternatively, because
tissue hypoxia plays a critical role in the primary and
secondary events that lead to ischemia-induced neuronal
death [4], tissue oxygenation with 100 vol% normobaric
oxygen (NBO) is generally thought a logical stroke strat-
egy that is often standard practice in acute ischemic
stroke patients despite controversial results and the
adverse potential of oxygen for exacerbating brain tissue
damage particularly during reperfusion [5-7].
In the present report, to better understand the
mechanisms of NBO on excitotoxic-ischemic insults, we
studied the effects of NBO on in vitro and in vivo mod-
els of excitotoxic insult and ischemic insult in neuronal
cell cultures, acute brain slices and rats. NBO treatment
was given in conditions shown previously to allow neu-
roprotection by some inert gases such as xenon, nitrous
oxide or helium [8-12]. We performed additional experi-
ments in in vitro models of excitotoxic/ischemic insults.
Our results indicate that NBO reduces excitotoxin-
induced neuronal degeneration but favors ischemia-
induced brain damage. These findings highlight the
complexity of the mechanisms involved by the use of
NBO in patients suffering acute ischemic stroke.
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Animals
All animal-use procedures were in accordance with the
framework of the French leg i s l a t i o no nb i o m e d i c a l
experimentation (agreement n° 14-27) and The Eur-
opean Communities Council Directive of 24 November
1986 (86/609/EEC). Before being used, rats and mice
were housed at 21 ± 0.5°C, in Perspex home cages with
free access to food and water. Light was maintained on
a light:dark reverse cycle, with lights on from 8:00 pm
to 8:00 am.
NMDA-induced brain damage
On the day of surgery, rats were anesthetized with 1.5%
halothane in oxygen alone, mounted on a stereotaxic
apparatus, and allowed breathing spontaneously
throughout the surgical intervention. A burr hole was
drilled and a micropipette (~10 μma tt h et i p )w a s
lowered into the right striatum (A: 0.6 mm, L: 3.0 mm,
V: 5.8 mm, from the bregma) in order to allow injection
of 50 nmol NMDA in 1 μL PBS (pH 7.4) over a 2-min
period. After an additional 5-min period, the micropip-
ette was removed, and the wounds sutured. During sur-
gery, body temperature was kept at 37.5 ± 0.5°C. The
rats waked up in their home cage after about 10 min,
where they had free access to food and water. One hour
after NMDA injection, the rats were treated with medi-
cal air (n = 7) or NBO (n = 12) as described below.
Sham rats were given saline alone (n = 8).
MCAO-induced cerebral ischemia
Rats were subjected to middle cerebral artery occlusion
(MCAO)-induced transient cerebral ischemia for 60
min. Rats were anesthetized with 1.5% halothane in oxy-
gen alone, and allowed breathing spontaneously
throughout the surgical intervention. A midline neck
incision was performed, and the right common carotid
artery was exposed. After coagulation of the branches of
the external carotid artery, a nylon thread (0.18 mm in
diameter) including a self-made distal cylinder of 3 mm
long and 0.38 mm diameter was inserted in the lumen
of the external carotid artery, directed into the internal
carotid artery up to the origin of the middle cerebral
artery, and secured to the external carotid artery. During
surgery, the animals were maintained normothermic at
37.5 ± 0.5°C using a feedback controlled thermostatic
heating pad. After surgery, rats were awaked and
allowed moving freely in their home cage with free
access to food and water. One hour after MCAO, the
nylon thread was removed under a short halothane
anesthesia of no more than 10-min duration to restore
blood flow. Then, after removal of the nylon thread, the
rats were returned to their home cage for one additional
hour before being treated with medical air (n = 10) or
NBO (n = 9) as described below. Sham rats (n = 6)
were subjected to the same protocol, except that the
nylon thread was just introduced in the external carotid
artery but not in the internal carotid artery; then after,
sham rats were exposed to medical air for 3 h.
Assessment of infarct size
Fifty hours after intrastriatal injection of NMDA or
induction of MCAO, the rats were killed by decapitation
under halothane anesthesia. The brain was rapidly
removed, frozen in isopentane, and placed at -80°C.
Coronal brain sections (20 μm) were cryostat-cut,
mounted on slides, and stained with thionin as follows:
slices were briefly immersed in water, stained with thio-
nin, dehydrated with serial alcohol and cleared with
xylene, and coverslipped with eukitt
® mounting. Brain
sections colored with thionin were digitized on a PC
computer. Then, volumes ofN M D A - i n d u c e dn e u r o n a l
death and MCAO-induced brain infarction were ana-
lyzed with an image analyzer (ImageJ
® software, Scion
corp., MD, USA) by two blinded observers. The obser-
vers’ estimations were averaged. The lesioned areas were
delineated by the pallor of staining in the necrotic tissue
as compared to the surrounding healthy tissue; NMDA-
and MCAO-induced brain damages were calculated by
integration of the infarcted surfaces over the whole
brain, corrected for tissue edema when needed (MCAO)
by calculating and taking into account the ipsilateral/
contralateral brain hemispheres ratio and expressed in
mm
3 of infarction volume.
Effects of NBO on NMDA-induced calcium influx in
cultured neuronal cells
Mouse cortical cultures of neurons were prepared from
14- to 15-days old embryos as described previously [13].
Cerebral cortices were dissected, dissociated and cultured
on 24-plates coated with 0.1 mg/ml poly-D-lysine
(Sigma) and 0.02 mg/ml laminin (Invitrogen) in Dulbec-
co’s modified Eagle medium (DMEM; Sigma) containing
5% fetal bovine serum (FBS), 5% horse serum and 2 mM
glutamine (all from Sigma). Cultures were kept at 37°C in
a humidified atmosphere containing 5% CO2.N e u r o n a l
cultures were used after 14 days in vitro. Cultures on
glass bottom dish (N°0, coverglass 0.085-0.13 mm; Mat-
tek Corporation; USA) were loaded for 45 min with 10
μM fura-2/acetoxymethyl ester (AM; F-1201, Invitrogen)
and 0.2% pluronic acid and incubated for an additional
15 min at room temperature in HEPES-buffered saline
solution containing (in mM) 116 NaCl; 5.4 KCl; 1.8
CaCl2;0 . 8M g S O 4;1 . 3N a H 2PO4; 12 HEPES; 5.5 glucose;
and 10 μM glycine at pH 7.45. Experiments were made at
room temperature with perfusion at 2 ml/min with a
peristaltic pump on the stage of an inverted microscope
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objective.
Fura-2 fluorescence emissions (>510 nm) evoked by
excitation through narrow band-pass filters (340 ± 5
nm/380 ± 6.5 nm) housed in a computer-controlled
filter wheel were recorded using an intensified CCD
camera (Coolsnap EZ). Ratio images were acquired on a
PC at a maximal time resolution of 2 s per successive
measurement using Metafluor 6.3 software (Universal
imaging Corporation, Chester, PA, USA). Measurements
were obtained simultaneously from 30-40 neurons per
randomly selected field (N = 3, n = 90-120 per condi-
tion). Changes in intracellular free Ca
2+ in cortical neu-
rons were induced by rapid NMDA stimulations of 25
μM for 30 seconds each with the presence of medical
air (controls) or NBO in the buffered saline solution.
OGD-induced cell injury in brain slices
Rats were killed by decapitation. Then, coronal brain
slices (400 μM thickness) including the striatum (ante-
riority: from + 1.2 to + 2 mm from Bregma) were cut
using a tissue chopper (Mickie Laboratory Engineering
Co., Gomshall, Surrey, UK), placed in a freshly prepared
artificial cerebrospinal fluid (aCSF) containing (in mM):
120 NaCl, 2 KCl, 2 CaCl2,2 6N a H C O 3,1 . 1 9M g S O 4,
1.18 KH2PO4, 11 d-glucose, and 30 HEPES, and allowed
to recover at room temperature for 45 min. Then, brain
slices were placed at 36 ± 0.5°C into individual vials
containing freshly prepared aCSF, saturated and con-
tinuously bubbled with 100 vol% oxygen (25 mL/min
per vial). Following a 30 min period of stabilization, the
incubation aCSF solution was renewed with oxygenated
aCSF maintained at 36°C; the slices were then incubated
for 1 h in order to allow recording basal levels of lactate
dehydrogenase (LDH). While control slices were incu-
bated for an additional 20-min period in the same con-
ditions, those corresponding to the “ischemic” group
were incubated in a glucose-free solution, saturated and
continuously bubbled with 100 vol% nitrogen (OGD
slices). After this 20-min period of OGD, to mimic
reperfusion and treatment, the medium was replaced in
all groups with freshly prepared aCSF solution, saturated
and continuously bubbled with either medical air or 100
vol% oxygen. Then, the incubation aCSF solution was
renewed every 1 h during the 3-h “reperfusion” period.
OGD-induced neuronal injury was quantified by the
amount of LDH released in the incubation solution
samples every 1 h; values were summed to determine
total levels of LDH released during the 3-h post-OGD
reperfusion period. LDH activity was measured using a
spectrophotometer at 340 nm in 50 μLo fi n c u b a t i o n
medium by following the oxidation (decrease in absor-
bance) of 100 mL b-NADH (3 mg in 10 mL PBS) in 20 μL
s o d i u mp y r u v a t e( 6 . 2 5m gi n1 0m LP B S )u s i n ga
microplate reader. The number of slices was n = 23-26 per
condition.
Gas pharmacology and treatment
Oxygen and air of medical grade were used. In vivo,
freely-moving rats were treated for a 3-h period with
either medical air (controls) or 100 vol% oxygen (NBO)
at a flow rate of 6 L/min in a closed chamber (10 L vol.)
fitted with a viewing window to allow observation. Such
conditions allowed maintaining carbon dioxide less than
0.03 vol% and humidity about 60-70%. All the animals
were treated with medical air or NBO according to a
blinded procedure. This consisted in giving each group
of animals a “secret” code that remained unknown to
the experimenters in charge of assessing the rat’s neuro-
logic and histologic outcome until the end of the study.
For in vitro experiments, neuronal cell cultures and
acute brain slices were continuously perfused with a
HEPES-buffered saline solution set at pH 7.4, previously
saturated with either NBO or medical air.
Statistical analysis
Data are given as mean ± sem. Date were analyzed using
Mann-Whitney non-parametric unpaired U-test. The
level of significance was set at P < 0.05.
Results
Effect of NBO on NMDA-induced neuronal death in vivo
We investigated the effects of NBO in rats that were
given an excitotoxic insult by intrastriatal infusion of 50
nmol NMDA. As illustrated in Figure 1, administration
of NMDA in the striatum led to excitotoxic neuronal
death of 18.3 ± 1.1 mm
3. In line with previous findings
that have shown redox modulation of the NMDA
Air
20
10
0
N
e
u
r
o
n
a
l
 
D
e
g
e
n
e
r
a
t
i
o
n
 
(
m
m
3
)
SAL NMDA
AIR NBO
A
NBO
AIR
B
# 
# *
Figure 1 Effect of NBO on NMDA-induced brain damage. (A)
Injection of NMDA led to significant brain damage as compared to
sham rats injected with saline. Rats treated with NBO (n = 12) 1h
after intrastriatal injection of NMDA showed a significant reduction
of brain damage as compared to control animals treated with
medical air (n = 7). (B) Typical brain slices obtained from rats
injected with NMDA and treated with either medical air or NBO.
Data are expressed as mean ± SEM (mm
3).
# P < 0.005 vs sham;
* P < 0.01 vs NMDA control rats treated with medical air.
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oxidation an inhibition of the NMDA receptor response
and glutamate-induced neuronal death [14,15], we
found that NBO administered 1 h after NMDA injection
reduced NMDA-induced neuronal death to 11.9 ± 0.7
mm
3 (P < 0.01), data corresponding to a decrease of
neuronal death of about 35%.
Effects of NBO on MCAO-induced brain damage
Further, we studied the effects of NBO on MCAO-
induced brain damage when given 1 h after MCAO
induction. As shown in Figure 2, as compared to sham
rats, MCAO control rats treated with medical air
showed ischemia-induced brain damage (at both the
cortical and subcortical level) and swelling of 218 ± 16
mm
3 and 23.9 ± 2.4%, respectively. NBO-treated rats
had greater volume of total infarction of 255 ± 11 mm
3
(P < 0.01) and brain swelling of 32.2 ± 2.6% (P < 0.01),
corresponding to a mean increase of respectively 17%
and 34% as compared to MCAO control rats treated
with medical air.
Effect of NBO on NMDA-induced calcium influx
and OGD-induced cell injury in vitro
Given the dichotomic effects of NBO on NMDA-induced
neuronal degeneration and MCAO-induced brain damage
in vivo, we performed additional experiments in vitro in
neuronal cell cultures exposed to NMDA stimulations and
brain slices exposed to experimental ischemia in the form
of OGD. Exposure to 25 μM NMDA led to an important
increase of 33% in intracellular free Ca
2+, a process known
as a key factor in excitotoxic neuronal death, which
recovered over the following minutes. In line with our in
vivo findings in rats injected with intrastriatal NMDA, we
found that NBO slightly but significantly reduced NMDA-
induced Ca
2+ influxes in neuronal cell cultures by about
17% (P < 0.001; Figure 3A). Alternatively, exposure to
OGD led to an increase in LDH release as compared to
sham slices. In line with our in vivo data in rats subjected
to MCAO-induced ischemia, post-ischemic NBO treat-
ment increased OGD-induced LDH release by 16 ± 0.3%
(P < 0.001; Figure 3B).
Discussion
In the present study, we investigated the effects of post-
insult NBO treatment (given 1 h after reperfusion) on
in vivo and in vitro models of excitotoxic-ischemic insult,
namely brain damage induced by intrastriatal administra-
tion of NMDA, MCAO-induced cerebral ischemia,
NMDA-induced calcium influxes in neuronal cell cultures,
and cell injury produced by OGD in brain slices.
We found that post-insult NBO treatment reduced
both NMDA-induced calcium influxes in vitro and
NMDA-induced neuronal degeneration in vivo,b u t
increased OGD-induced cell injury in vitro and MCAO-
induced cortical brain damage in vivo. Taken together,
these results indicate that post-insult NBO treatment
reduces excitotoxin-induced calcium influx and subse-
quent neuronal degeneration but favors ischemia-
induced brain damage and neuronal death. Previous
investigations have demonstrated that NBO given during
ischemia and/or immediately after ischemia may be a
safe and effective stroke therapy [16-20] whereas in con-
trast NBO given during reperfusion may exacerbate brain
tissue damage [6,21,22]. Given that NBO shows ability at
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Figure 2 Effects of NBO on MCAO-induced brain damage and
behavioral motor deficits. (A) NBO-treated rats (n = 9) had
greater total and striatal damage, and showed a trend toward an
increase in cortical brain damage, as compared with MCAO control
rats treated with medical air (n = 10). Sham animals showed no
brain damage (n = 6; data not shown). (B) NBO further increased
brain edema and swelling as compared to MCAO control rats
treated with medical air. (C) Typical examples of brain slices in
MCAO rats treated with either medical air or NBO. Data are
expressed as mean ± SEM (mm
3). * P < 0.01 vs MCAO control rats
treated with medical air.
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Figure 3 Effects of NBO on NMDA-evoked Ca
2+ influx in
cortical neuronal cultures and OGD-induced LDH release in
acute brain slices. (A) Exposure to NMDA (25 μM) produces a
rapid increase in intracellular free Ca
2+, which recovered over the
following minutes. NBO reduced NMDA-induced Ca
2+ influx by
~20%. For each experiment, N = 3, n = 90-120. (B) Exposure to
OGD produces an increase in LDH release, as a marker of cell injury.
NBO increases OGD-induced LDH release by ~25% as compared
with OGD control slices treated with medical air. n = 23-26 per
condition. Data are expressed as mean ± SEM.
# P < 0.0005 vs sham;
* P< 0.001 vs NMDA or OGD.
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well known to play a critical role in the development of
ischemia-induced neuronal degeneration during the
intra-ischemic period (before reperfusion), it is likely that
the adverse effects of NBO at increasing ischemia-
induced brain damage could occur through vascular-
endothelial processes, which are known to be altered dur-
ing and after reperfusion. Also, since both types of lesion
are reduced by both intra- and post-ischemic inert gases
that possess antagonistic properties at the NMDA recep-
tor [9-12], the dichotomic effects of NBO on excitotoxin-
and ischemia-induced neuronal death further indicate
that NBO when given after reperfusion would favor some
of the deleterious mechanisms that participate to neuro-
nal death after a hypoxic/ischemic insult in a manner
that overcomes its anti-excitotoxic properties. In that
way, the adverse potential of oxygen for exacerbating tis-
s u ed a m a g et h r o u g ht h ep r o d u c t i o no fr e a c t i v eo x y g e n
species has been well documented particularly during
reperfusion [5-7,21,22], but also discussed [16].
Conclusions
I nc o n c l u s i o n ,i ts h o u l db ek e p ti nm i n dt h a ts of a ra s
today clinical trials with NBO have failed to show bene-
fits in acute ischemic stroke patients [23,24]. By demon-
strating for the first time to the best of our knowledge
that NBO reduces excitotoxin-induced cell injury and as
reported previously favors ischemia-induced cell injury
when given after reperfusion, the present study suggests
that NBO could be given to patients suffering acute
ischemic stroke, and then stopped once reperfusion has
occurred. Clinical trials with NBO could be designed in
that way.
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